Observation of curative effection of Milli Fire Needle in treating Localized Scleroderma

Feasibility and Safety of Milli Fire Needle in Localized Scleroderma Treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042327

Enrollment

Unknown

Registered

2021-01-19

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Localized Scleroderma

Interventions

treatment group:Milli Fire Needle+0.1% tacrolimus oinment

control group:0.1% tacrolimus oinment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18~70 years; 2. Diagnosed as morphea by over three experienced dermatologists or biopsy; 3. Skin Thickness score two or more; 4. Willing to accept Milli Fire Needle therapy.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. Used to be fainting during acupuncture treatment; 3. Prior to hypertension, diabetes, heart failure; 4. Active infection or ulcer of the lesion.

Design outcomes

Primary

Measure	Time frame
Localized Scleroderma Cutaneous Assessment Tool;derma thickness;	—

Secondary

Measure	Time frame
Life Quality;derma elasticity;dermal temperature;	—

Countries

China

Contacts

Public ContactZhuKe

Guangzhou University of Traditional Chinese Medicine

32787880@qq.com+86 15989120761

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026